2025. The Protective Effect of Dapagliflozin Against Contrast-Induced Nephropathy After Percutaneous Coronary Catheterization in Patients Moderate to High-Risk for CIN. Vascular and Endovascular Review. 8, 5s (Nov. 2025), 154–161. DOI:https://doi.org/10.64149/J.Ver.8.5s.154-161.